IUD Selection for Women in Their 50s

Primary Recommendation: Levonorgestrel IUD

The American College of Radiology recommends the levonorgestrel IUD as first-line medical management for heavy menstrual bleeding, with a failure rate of less than 1% and the added benefit of managing perimenopausal heavy menstrual bleeding in women in their 50s 1, 3
The levonorgestrel IUD is FDA-approved for 5 years but demonstrates effectiveness for up to 7-8 years, with a cumulative failure rate of only 0.68% during years 6-8, making it a highly effective contraceptive method for women in their 50s 3
The levonorgestrel IUD contains no estrogen, eliminating estrogen-associated risks such as venous thromboembolism (VTE), which becomes increasingly important as cardiovascular risk factors accumulate with age in women in their 50s 1, 3

The copper IUD is the preferred choice when the patient desires completely hormone-free contraception, has a history of hormone-sensitive conditions, or experiences unacceptable side effects from progestin, with a failure rate of less than 1% 1, 4
The copper IUD is FDA-approved for 10 years and remains effective for at least 12 years, making it a long-term contraceptive option for women in their 50s 4

Women in their 50s frequently have accumulated cardiovascular risk factors that make estrogen-containing contraceptives inappropriate, and both IUD types are Category 1 (unrestricted use) for women with controlled hypertension 6, 7
The CDC classification for women aged >45 years using levonorgestrel IUDs is Category 1 (no restrictions), compared to Category 2 for combined hormonal contraceptives in women aged ≥40 years, making the levonorgestrel IUD a safe option for women in their 50s 5

The American College of Obstetricians and Gynecologists recommends assessing for absolute contraindications and evaluating cardiovascular risk factors and history of VTE/stroke when selecting an IUD for women in their 50s, and favoring IUDs over hormonal contraception if present 6, 7